Cite
MLA Citation
R. Kischel et al.. “Preclinical characterization of an EGFRvIII/CD3 specific BiTE® antibody construct for the treatment of glioblastoma multiforme.” European journal of cancer, vol. 69, n.d., pp. S96–. http://access.bl.uk/ark:/81055/vdc_100039473424.0x000044